ProfileGDS4718 / 1554543_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 47% 42% 30% 47% 44% 32% 40% 32% 48% 44% 39% 47% 27% 38% 36% 48% 34% 40% 36% 41% 32% 37% 35% 48% 45% 41% 48% 47% 66% 37% 36% 30% 50% 50% 45% 33% 39% 33% 47% 30% 39% 40% 41% 35% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.3573347
GSM549102patient 115, normal, homogenized [OPG study]5.1039542
GSM549104patient 119, normal, homogenized [OPG study]4.5135130
GSM549108patient 138, normal, homogenized [OPG study]5.3743447
GSM549119patient 077, normal, homogenized [OPG study]5.1960844
GSM549133patient 032, cancer, homogenized [OPG study]4.5711132
GSM549139patient 042, cancer, homogenized [OPG study]4.9547740
GSM549099patient 107, normal, homogenized [OPG study]4.6402332
GSM549109patient 139, normal, homogenized [OPG study]5.4418348
GSM549110patient 046, normal, homogenized [OPG study]5.2016844
GSM549114patient 063, normal, homogenized [OPG study]4.9216839
GSM549122patient 082, normal, homogenized [OPG study]5.3740247
GSM549134patient 033, cancer, homogenized [OPG study]4.3940527
GSM549136patient 036, cancer, homogenized [OPG study]4.8390538
GSM549140patient 044, cancer, homogenized [OPG study]4.7565936
GSM549111patient 047, normal, homogenized [OPG study]5.387148
GSM549113patient 057, normal, homogenized [OPG study]4.6569334
GSM549132patient 031, cancer, homogenized [OPG study]4.9598240
GSM549137patient 038, cancer, homogenized [OPG study]4.7780736
GSM549142patient 047, cancer, homogenized [OPG study]5.1456841
GSM549100patient 110, normal, homogenized [OPG study]4.6510832
GSM549107patient 135, normal, homogenized [OPG study]4.8119737
GSM549115patient 068, normal, homogenized [OPG study]4.6825835
GSM549116patient 072, normal, homogenized [OPG study]5.3999648
GSM549120patient 078, normal, homogenized [OPG study]5.2536545
GSM549131patient 030, cancer, homogenized [OPG study]4.9842641
GSM549118patient 074, normal, homogenized [OPG study]5.3815148
GSM549129patient 027, cancer, homogenized [OPG study]5.3558247
GSM549123patient 088, normal, homogenized [OPG study]6.5337366
GSM549124patient 006, cancer, homogenized [OPG study]4.8741437
GSM549126patient 015, cancer, homogenized [OPG study]4.7961436
GSM549128patient 025, cancer, homogenized [OPG study]4.5289330
GSM549103patient 117, normal, homogenized [OPG study]5.5551850
GSM549117patient 073, normal, homogenized [OPG study]5.4942350
GSM549138patient 041, cancer, homogenized [OPG study]5.2265945
GSM549141patient 045, cancer, homogenized [OPG study]4.6261833
GSM549130patient 028, cancer, homogenized [OPG study]4.955939
GSM549101patient 111, normal, homogenized [OPG study]4.7175533
GSM549105patient 128, normal, homogenized [OPG study]5.3559647
GSM549106patient 134, normal, homogenized [OPG study]4.5018230
GSM549112patient 048, normal, homogenized [OPG study]4.9300139
GSM549125patient 011, cancer, homogenized [OPG study]5.0169640
GSM549127patient 024, cancer, homogenized [OPG study]5.0155941
GSM549135patient 035, cancer, homogenized [OPG study]4.7280935